Financial Times FT.com

Pfizer/Wyeth animal health products divestiture in 'normal course stages'

By Nadia Damouni and Sasha Damouni

Published: May 22 2009 13:48 | Last updated: May 22 2009 13:48

Email options

The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.Terms of use |Privacy policy

* required fields



(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)